Kolexia
Corpechot Christophe Gastro-entérologie
Corpechot Christophe
Gastro-entérologie
Hôpital Saint-Antoine
Paris, France
199 Activités
1 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Cirrhose biliaire Angiocholite Fibrose Angiocholite sclérosante Cirrhose du foie Maladies du foie Cholestase Hépatite Hépatite auto-immune

Collaborateurs

Voir plus
Chazouilleres Olivier
Chazouilleres Olivier
Hôpital Saint-Antoine, Paris, France
Poupon Raoul
Poupon Raoul
Cabinet libéral, Neuilly-sur-Seine, France
Lemoinne Sara
Lemoinne Sara
Hôpital Saint-Antoine, Paris, France
Arrive Lionel
Arrive Lionel
Hôpital Saint-Antoine, Paris, France

Industries

Voir plus
ADVANZ PHARMA FRANCE
6 collaboration(s)
Dernière en 2022
Ipsen
4 collaboration(s)
Dernière en 2023
Siemens Healthcare
2 collaboration(s)
Dernière en 2020
Abbvie
1 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
ELATIVE: A Double-blind, Randomized, Placebo-Controlled Study and Open-label Long Term Extension to Evaluate the Efficacy and Safety of Elafibranor 80 mg in Patients With Primary Biliary Cholangitis With Inadequate Response or Intolerance to Ursodeoxycholic Acid
Essai Clinique (Ipsen)   28 février 2024
CBP-HOPE: Randomized Controlled Trial of Psychoeducational and Hypnosis Interventions on the Fatigue Associated With Primary Biliary Cholangitis in Women (CBP-HOPE)
Essai Clinique (Assistance publique – Hôpitaux de Paris)   28 février 2024
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.
The New England journal of medicine   21 février 2024
Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN): A Two-part, Randomized, Placebo Controlled, Double Blind, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Linerixibat for the Treatment of Cholestatic Pruritus in Participants With Primary Biliary Cholangitis (PBC)
Essai Clinique (GSK)   13 février 2024
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial.
Journal of autoimmunity   07 février 2024
Longer transplant-free and liver-related event-free survival in obeticholic acid-treated patients with primary biliary cholangitis compared to external controls from two large real-world cohorts
Abstracts of the 56th A.I.S.F. - Italian Association for theStudy of the Liver - Annual Meeting 2024Rome, March 14th -15th, 2024   01 février 2024
Exploring the impact of ursodeoxycholic acid therapy on COVID-19 in a real-word setting.
Journal of medical virology   22 janvier 2024
Reply: Improving access to transient elastography data for Real-World Prognostic Applications in primary biliary cholangitis.
Hepatology (Baltimore, Md.)   27 décembre 2023
Litiasis biliar
EMC - Tratado de Medicina   22 décembre 2023
Cholestases intrahépatiques familiales de l’adulte
Edimark   18 décembre 2023